Selected research
Market Structure
Global Recombinant Collagen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Recombinant Collagen market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Recombinant Collagen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Recombinant Collagen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Recombinant Collagen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Recombinant Collagen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Recombinant Collagen include Giant Biogene, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu JLand Biotech, Jiangsu Chuangjian Medical Technology, ProColl, Evonik, Creative BioMart and CollPlant, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Recombinant Collagen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Recombinant Collagen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Recombinant Collagen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Recombinant Collagen market size, projected growth trends, production technologies, key applications, and end-use industries.
Recombinant Collagen Segment by Company
Giant Biogene
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
ProColl
Evonik
Creative BioMart
CollPlant
Recombinant Collagen Segment by Type
Recombinant Type III Collagen
Recombinant Type I Collagen
Recombinant Type XVII Collagen
Recombinant Collagen Segment by Application
Biomedicine
Beauty and Skin Care
Other
Recombinant Collagen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Collagen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Collagen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Collagen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Recombinant Collagen market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Collagen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Collagen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Recombinant Collagen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Recombinant Type III Collagen
- Recombinant Type I Collagen
- Recombinant Type XVII Collagen
Applications
- Biomedicine
- Beauty and Skin Care
- Other
Companies covered
- Giant Biogene
- Shanxi Jinbo Bio-Pharmaceutical
- Jiangsu JLand Biotech
- Jiangsu Chuangjian Medical Technology
- ProColl
- Evonik
- Creative BioMart
- CollPlant
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Recombinant Collagen Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Recombinant Collagen Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Recombinant Collagen Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Recombinant Collagen Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Recombinant Collagen Market Dynamics
- 2.1 Recombinant Collagen Industry Trends
- 2.2 Recombinant Collagen Industry Drivers
- 2.3 Recombinant Collagen Industry Opportunities and Challenges
- 2.4 Recombinant Collagen Industry Restraints
3 Recombinant Collagen Market by Manufacturers
- 3.1 Global Recombinant Collagen Revenue by Manufacturers (2021-2026)
- 3.2 Global Recombinant Collagen Sales by Manufacturers (2021-2026)
- 3.3 Global Recombinant Collagen Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Recombinant Collagen Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Recombinant Collagen Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Recombinant Collagen Manufacturers, Product Type & Application
- 3.7 Global Recombinant Collagen Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Recombinant Collagen Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Recombinant Collagen Players Market Share by Revenue in 2025
- 3.8.3 2025 Recombinant Collagen Tier 1, Tier 2, and Tier 3
4 Recombinant Collagen Market by Type
- 4.1 Recombinant Collagen Type Introduction
- 4.1.1 Recombinant Type III Collagen
- 4.1.2 Recombinant Type I Collagen
- 4.1.3 Recombinant Type XVII Collagen
- 4.2 Global Recombinant Collagen Sales by Type
- 4.2.1 Global Recombinant Collagen Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Recombinant Collagen Sales by Type (2021-2032)
- 4.2.3 Global Recombinant Collagen Sales Market Share by Type (2021-2032)
- 4.3 Global Recombinant Collagen Revenue by Type
- 4.3.1 Global Recombinant Collagen Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Recombinant Collagen Revenue by Type (2021-2032)
- 4.3.3 Global Recombinant Collagen Revenue Market Share by Type (2021-2032)
5 Recombinant Collagen Market by Application
- 5.1 Recombinant Collagen Application Introduction
- 5.1.1 Biomedicine
- 5.1.2 Beauty and Skin Care
- 5.1.3 Other
- 5.2 Global Recombinant Collagen Sales by Application
- 5.2.1 Global Recombinant Collagen Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Recombinant Collagen Sales by Application (2021-2032)
- 5.2.3 Global Recombinant Collagen Sales Market Share by Application (2021-2032)
- 5.3 Global Recombinant Collagen Revenue by Application
- 5.3.1 Global Recombinant Collagen Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Recombinant Collagen Revenue by Application (2021-2032)
- 5.3.3 Global Recombinant Collagen Revenue Market Share by Application (2021-2032)
6 Global Recombinant Collagen Sales by Region
- 6.1 Global Recombinant Collagen Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Recombinant Collagen Sales by Region (2021-2032)
- 6.2.1 Global Recombinant Collagen Sales by Region (2021-2026)
- 6.2.2 Global Recombinant Collagen Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Recombinant Collagen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Recombinant Collagen Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Recombinant Collagen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Recombinant Collagen Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Recombinant Collagen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Recombinant Collagen Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Recombinant Collagen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Recombinant Collagen Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Recombinant Collagen Revenue by Region
- 7.1 Global Recombinant Collagen Revenue by Region
- 7.1.1 Global Recombinant Collagen Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Recombinant Collagen Revenue by Region (2021-2026)
- 7.1.3 Global Recombinant Collagen Revenue by Region (2027-2032)
- 7.1.4 Global Recombinant Collagen Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Recombinant Collagen Revenue (2021-2032)
- 7.2.2 North America Recombinant Collagen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Recombinant Collagen Revenue (2021-2032)
- 7.3.2 Europe Recombinant Collagen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Recombinant Collagen Revenue (2021-2032)
- 7.4.2 Asia-Pacific Recombinant Collagen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Recombinant Collagen Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Recombinant Collagen Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Giant Biogene
- 8.1.1 Giant Biogene Company Information
- 8.1.2 Giant Biogene Business Overview
- 8.1.3 Giant Biogene Recombinant Collagen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Giant Biogene Recombinant Collagen Product Portfolio
- 8.1.5 Giant Biogene Recent Developments
- 8.2 Shanxi Jinbo Bio-Pharmaceutical
- 8.2.1 Shanxi Jinbo Bio-Pharmaceutical Company Information
- 8.2.2 Shanxi Jinbo Bio-Pharmaceutical Business Overview
- 8.2.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Collagen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Collagen Product Portfolio
- 8.2.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments
- 8.3 Jiangsu JLand Biotech
- 8.3.1 Jiangsu JLand Biotech Company Information
- 8.3.2 Jiangsu JLand Biotech Business Overview
- 8.3.3 Jiangsu JLand Biotech Recombinant Collagen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jiangsu JLand Biotech Recombinant Collagen Product Portfolio
- 8.3.5 Jiangsu JLand Biotech Recent Developments
- 8.4 Jiangsu Chuangjian Medical Technology
- 8.4.1 Jiangsu Chuangjian Medical Technology Company Information
- 8.4.2 Jiangsu Chuangjian Medical Technology Business Overview
- 8.4.3 Jiangsu Chuangjian Medical Technology Recombinant Collagen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Jiangsu Chuangjian Medical Technology Recombinant Collagen Product Portfolio
- 8.4.5 Jiangsu Chuangjian Medical Technology Recent Developments
- 8.5 ProColl
- 8.5.1 ProColl Company Information
- 8.5.2 ProColl Business Overview
- 8.5.3 ProColl Recombinant Collagen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 ProColl Recombinant Collagen Product Portfolio
- 8.5.5 ProColl Recent Developments
- 8.6 Evonik
- 8.6.1 Evonik Company Information
- 8.6.2 Evonik Business Overview
- 8.6.3 Evonik Recombinant Collagen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Evonik Recombinant Collagen Product Portfolio
- 8.6.5 Evonik Recent Developments
- 8.7 Creative BioMart
- 8.7.1 Creative BioMart Company Information
- 8.7.2 Creative BioMart Business Overview
- 8.7.3 Creative BioMart Recombinant Collagen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Creative BioMart Recombinant Collagen Product Portfolio
- 8.7.5 Creative BioMart Recent Developments
- 8.8 CollPlant
- 8.8.1 CollPlant Company Information
- 8.8.2 CollPlant Business Overview
- 8.8.3 CollPlant Recombinant Collagen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 CollPlant Recombinant Collagen Product Portfolio
- 8.8.5 CollPlant Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Recombinant Collagen Value Chain Analysis
- 9.1.1 Recombinant Collagen Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Recombinant Collagen Production Mode & Process
- 9.2 Recombinant Collagen Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Recombinant Collagen Distributors
- 9.2.3 Recombinant Collagen Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst